arXiv Machine Learning July 28, 2026 By Tinghui Jin, Kedu Jin, Ying Li, Guanghui Ren, Jingzhi Xue, Shiyu Zhou, Xiaoli Dai, Li-bin Wei, Xijing Chen, Di Zhao, Jinfeng Liu

MEGA-CL: A Molecular Foundation Model for Generalizable ADMET Prediction through Graph External Attention and Contrastive Learning

Read the original on arXiv Machine Learning →

arXiv:2607. 24314v1 Announce Type: new Abstract: Predicting the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of small molecules remains a major challenge in drug discovery.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv Machine Learning.

arXiv Machine Learning

4d ago

Benchmarking graph-based models for in-silico toxicity prediction in drug discovery

arXiv:2609.37555v1 Announce Type: new Abstract: Drug discovery is a costly and high-risk process, where toxicity-related failures remain a major cause of attrition in both preclinical and clinical st...

By Noel Suarez-Barro, Manuel Lama, Juan C. Vidal

benchmarks safety

arXiv AI

Jun 9

Pharmacogenomic Knowledge Graph Augmentation for Graph Neural Network-Based Drug-Drug Interaction Prediction

arXiv:2606. 07698v1 Announce Type: cross Abstract: Graph neural networks (GNNs) applied to drug-drug interaction (DDI) prediction rely exclusively on molecular structure encoded as SMILES-derived graphs.

By Juergen Dietrich

rag multimodal benchmarks safety

arXiv Machine Learning

Jul 9

Asymmetric Focal Loss Improves Graph Neural Network Prediction of Drug-Drug Interactions

arXiv:2607. 07611v1 Announce Type: new Abstract: Background: Graph neural networks improve computational prediction of polypharmacy side effects, but standard binary cross-entropy training allocates equal capacity to well-classified and difficult examples, potentially missing clinically significant interactions.

By Faranak Hatami, Mousa Moradi

rag

arXiv AI

Sep 25

SMILESGNN: Interpretable Clinical Toxicity Prediction via SMILES-Graph Cross-Attention Fusion

SMILESGNN is a multimodal architecture that fuses a SMILES Transformer encoder with a GATv2 graph encoder through cross‑attention, enabling interpretable clinical toxicity predictions. The model retains an explicit graph branch, allowing GNNExplainer to identify substructures linked to toxicity. On the ClinTox dataset it achieves an AUC‑ROC of 0.987 and F1 of 0.906 with only 0.4 M parameters, while on Tox21 it attains a mean AUC‑ROC of 0.750, comparable to strong single‑modality baselines.

By Quang Minh Nguyen, Thuy Quynh Nguyen, Duc Minh Le, Ho Nhat Minh Nguyen, Thanh Long Dai Doan, Trong Nghia Nguyen

llms multimodal safety

arXiv Machine Learning

Jun 11

Probabilistic Contrastive Pretraining for Multi-task ADME Property Prediction

arXiv:2606. 11508v1 Announce Type: new Abstract: Accurate prediction of absorption, distribution, metabolism, and excretion (ADME) properties is critical to drug discovery, but remains challenging because ADME endpoints are noisy, interdependent, and often data-limited.

By Yifan Xue, Srimukh Prasad Veccham, Saee Paliwal, Tyler Shimko, Micha Livne

llms fine-tuning

arXiv Machine Learning

Jun 9

Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction

arXiv:2604. 26498v3 Announce Type: replace Abstract: The rapid growth of molecular foundation models and large language models (LLMs) has encouraged a scale centred view of AI in drug discovery, in which larger pretrained models are expected to supersede compact cheminformatics models.

By Jinjiang Guo, Sheng Ding

llms benchmarks safety

One email a morning, machine-written

Related stories

Benchmarking graph-based models for in-silico toxicity prediction in drug discovery

Pharmacogenomic Knowledge Graph Augmentation for Graph Neural Network-Based Drug-Drug Interaction Prediction

Asymmetric Focal Loss Improves Graph Neural Network Prediction of Drug-Drug Interactions

SMILESGNN: Interpretable Clinical Toxicity Prediction via SMILES-Graph Cross-Attention Fusion

Probabilistic Contrastive Pretraining for Multi-task ADME Property Prediction

Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction